1. Targeting long non-coding RNA to therapeutically upregulate gene expression.
   Claes Wahlestedt, 2013, Nat Rev Drug Discov CrossRef
2. Small RNAs/Cancer
   B.M. Ryan, 2016 CrossRef
3. Targeting long non-coding RNAs in cancers: progress and prospects.
   Chi Han Li et al, 2013, Int. J. Biochem. Cell Biol. CrossRef
4. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies
   Fan Zhang et al, 2016, Tumor Biol. CrossRef
5. MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression
   Katharina Ruebel et al, 2010, Mod Pathol CrossRef
6. Down-regulation of miR-106b suppresses the growth of human glioma cells
   Anling Zhang et al, 2013, J Neurooncol CrossRef
7. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma
   Sara Tomaselli et al, 2015, Genome Biol CrossRef
8. Natural antisense transcripts as therapeutic targets
   Paul Halley et al, 2013, Drug Discovery Today: Therapeutic Strategies CrossRef
9. Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets
   Simone Treiger Sredni et al, 2010, Childs Nerv Syst CrossRef
10. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs
    E L McKinsey et al, 2011, Oncogene CrossRef
11. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens
    Aysegül Ilhan-Mutlu et al, 2013, J Neurooncol CrossRef
12. MiR-222 Targeted PUMA to Improve Sensitization of UM1 Cells to Cisplatin
    Fangfang Jiang et al, 2014, IJMS CrossRef
13. Non-Coding RNAs and Cancer
    Federica Calore et al, 2013, IJMS CrossRef
14. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia
    Hellinida Thomadaki et al, 2012, Clinical Biochemistry CrossRef
15. Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.
    Eleonora Brognara, 0 CrossRef
16. MicroRNAs as Regulators of Neural Stem Cell-Related Pathways in Glioblastoma Multiforme
    Pilar González-Gómez et al, 2011, Mol Neurobiol CrossRef
17. Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept
    Bo Halle et al, 2016, J Neurooncol CrossRef
18. Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma.
    Guangbing Li et al, 2014, Biomed Res Int CrossRef
19. Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells
    Alessandro Bertucci et al, 2015, Small CrossRef
20. Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma
    Jian-Kai Yang et al, 2017, J Neurooncol CrossRef
21. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease.
    Arunoday Bhan et al, 2014, ChemMedChem CrossRef
22. Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
    R Gan et al, 2014, Cancer Gene Ther CrossRef
23. Hypoxia-inducible regulation of placental BOK expression
    Daochun Luo et al, 2014, Biochem. J. CrossRef
24. Recovery of MicroRNA from Stored Human Peripheral Blood Samples
    Eric Seelenfreund et al, 2011, Biopreservation and Biobanking CrossRef
25. Long Noncoding RNA ( lncRNA ): Functions in Health and Disease
    Arunoday Bhan et al, 2017 CrossRef
26. Human Primary Articular Chondrocytes, Chondroblasts-Like Cells, and Dedifferentiated Chondrocytes: Differences in Gene, MicroRNA, and Protein Expression and Phenotype
    Tommy A. Karlsen et al, 2011, Tissue Engineering Part C: Methods CrossRef
27. MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas
    Yingyi Wang et al, 2012, J Neurooncol CrossRef
28. CUG-binding protein represses translation of p27Kip1 mRNA through its internal ribosomal entry site
    Yuhuan Zheng et al, 2011, RNA Biology CrossRef
29. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
    Zhang Chun-zhi et al, 2010, BMC Cancer CrossRef
30. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells
    Yunzhi Zhang et al, 2011, Mol Cell Biochem CrossRef
31. Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in Cancer
    Andrei V. Chernov et al, 2010, J. Biol. Chem. CrossRef
32. MicroRNA–target cross-talks: Key players in glioblastoma multiforme
    Eman Ali Toraih et al, 2017, Tumour Biol. CrossRef
33. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway
    Yanhua Li et al, 2017, Dig Dis Sci CrossRef
34. MicroRNAs in Cancer (An Overview)
    Manuela Ferracin et al, 2011 CrossRef
35. Molecular methods for validation of the biological activity of peptide nucleic acids targeting microRNAs.
    Eleonora Brognara, 0 CrossRef
36. RNAi in Malignant Brain Tumors: Relevance to Molecular and Translational Research
    Mitsutoshi Nakada et al, 2010 CrossRef
37. MicroRNAs in Predicting Radiotherapy and Chemotherapy Response
    Emily J. Noonan et al, 2011 CrossRef
38. Role of MicroRNA in Glioma
    Yongping You et al, 2012 CrossRef
39. MicroRNA-222-3p associated with Helicobacter pylori targets HIPK2 to promote cell proliferation, invasion, and inhibits apoptosis in gastric cancer
    Xiaoyan Tan et al, 2018, J. Cell. Biochem. CrossRef
40. Long Non-Coding RNAs as Strategic Molecules to Augment the Radiation Therapy in Esophageal Squamous Cell Carcinoma
    Uttam Sharma et al, 2020, IJMS CrossRef
41. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
    Amanda Shea et al, 2016, Cancer Med CrossRef
42. Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer
    Reza Nedaeinia et al, 2017, J. Cell. Biochem. CrossRef
43. High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
    Chunzhi Zhang et al, 2012, J Transl Med CrossRef
44. MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
    Chun-Zhi Zhang et al, 2010, Mol Cancer CrossRef
45. miR‐221/222 suppression induced by activation of the cAMP/PKA/CREB1 pathway is required for cAMP‐induced bidirectional differentiation of glioma cells
    Qian Liu et al, 2021, FEBS Lett CrossRef
46. Small RNAs/Cancer
    B.M. Ryan, 2016 CrossRef
47. Up-regulation of BOK-AS1, FAM215A and FEZF1-AS1 lncRNAs and their potency as moderate diagnostic biomarkers in gastric cancer
    Hesam Moazzen et al, 2023, Pathology - Research and Practice CrossRef
48. Increased miR‐222 in H. pylori‐associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK
    Na Li et al, 2012, FEBS Letters CrossRef
49. microRNAs, RNA binding proteins and cancer
    Reuven Agami, 2010, Eur J Clin Investigation CrossRef
50. Reduction of Dicer impairs Schwann cell differentiation and myelination
    Jonathan D. Verrier et al, 2010, J of Neuroscience Research CrossRef
51. MiR‐139 Inhibits Mcl‐1 Expression and Potentiates TMZ‐Induced Apoptosis in Glioma
    Rui‐Yan Li et al, 2013, CNS Neurosci Ther CrossRef
52. Autophagy Dysfunction: The Kernel of Hair Loss?
    Xiaofan Jin et al, 2024, CCID CrossRef